South San Francisco, CA
Esker is a precision medicines company looking to eliminate the “all-comers” approach that is seen with today’s treatments for people with autoimmune disease. Even with the innovation of the last decade, many patients continue to cycle through the approved therapies while continuing to look for the right therapy to alleviate the impact of their disease without life-impacting side effects. Esker leverages a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.
eskertx.comThese are collections Esker Therapeutics is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$40,000,000
Series C
$259,000,000
IPO
Unknown
Series B
$200,000,000
Series A
$70,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Esker Therapeutics.